In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few BPC 157 and Female Fertility: Effects, Mechanisms, Safety and Risks The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides and BPC 157 for Pain: PainExam Podcast Apple Podcasts The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and